Frequently Asked Questions
These FAQs provide basic information about our services, but patients should always consult their healthcare provider for personalized advice and guidance regarding its use.
Spravato
Spravato™ is a prescription medicine administered as a nasal spray and used along with an antidepressant, taken by mouth to treat: Adults with treatment-resistant depression (TRD) Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions.
Spravato™ is FDA approved exclusively for adults living with depression who have not responded well to other treatments. Spravato is for adults who have treatment-resistant depression. The drug may also be used to help adults who are having suicidal thoughts because of severe depressive disorder. To determine if Spravato™ is right for you, contact the team at Roseville Center to discuss your specific situation and treatment options.
Although Spravato™ esketamine is administered as a nasal spray, people are not permitted to purchase it for home use. Patients may receive Spravato under medical supervision at a clinic or doctor’s office that has been certified by the maker of Spravato™ as an authorized provider. Wilshire Institute is a certified authorized provider of Spravato™.
Spravato™ is not for everyone. Spravato™ is only approved for adults suffering from Treatment Resistant Depression (TRD). To determine if you qualify, your doctor will work with you on the qualification process. Contact the team at Wilshire Institute to discuss your specific situation, review the qualification requirements, and learn about treatment options.
Spravato™ is covered by most insurance. Wilshire Institute Patient Advocates will work with you and your insurance to ensure treatments are available to you as quickly as possible and with minimal out-of-pocket cost. In addition to the coverage provided by your insurance, Janssen, the maker of Spravato, offers a program to help cover much of your out-of-pocket co-share or co-pay. You will have a personal Patient Advocate assigned to you that will manage all of the insurance and related paperwork so that you can focus on your treatments and your recovery. To learn more, call us now and speak to a Patient Advocate today.
Call Wilshire Institute to learn more about Spravato™. For additional information about Spravato™ from Janssen Pharmaceuticals, Inc., the maker of Spravato™, visit www.spravato.com
IV Ketamine
In addition to being safe, ketamine is fast acting. It quickly balances the activity of a neurotransmitter called glutamate, which in turn lessens the symptoms of mental health disorders such as depression.
Following an IV infusion of ketamine, most patients see an improvement within hours. By comparison, commonly used antidepressants such as selective serotonin reuptake inhibitors take weeks to produce symptom relief.
Extensive research shows that ketamine is exceptionally useful for treatment-resistant depression. In addition to serving as a general antidepressant, recent landmark studies support its benefit for treating acute suicidality.
Studies also indicate that ketamine is beneficial for other mental health conditions such as anxiety, particularly in patients who don’t respond to other medications. Further data suggests that Ketamine may be helpful in treating bipolar disorder, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD).
Ketamine has a successful history of relieving chronic pain. It treats a range of chronic pain disorders including complex regional pain syndrome and some neuropathic pain conditions such as fibromyalgia.
Ketamine may be administered in several ways, but intravenous (IV) infusion is the most successful. The treatment is administered in a quiet, private suite at Wilshire Institute.
Most treatments take about 90 minutes which includes preparation time, the ketamine infusion, and post-infusion monitoring. During this time, most patients prefer to close their eyes and rest quietly or listen to soft music while they relax. You will be continuously monitored by medical staff during the entire process. Following your infusion, you can’t drive for the rest of the day, so you will need to have a family member or friend drive you home.